John Greene

1.4k total citations · 1 hit paper
38 papers, 1.0k citations indexed

About

John Greene is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, John Greene has authored 38 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in John Greene's work include Circular RNAs in diseases (5 papers), Prostate Cancer Treatment and Research (5 papers) and MicroRNA in disease regulation (4 papers). John Greene is often cited by papers focused on Circular RNAs in diseases (5 papers), Prostate Cancer Treatment and Research (5 papers) and MicroRNA in disease regulation (4 papers). John Greene collaborates with scholars based in Ireland, United States and United Kingdom. John Greene's co-authors include Stephen P. Finn, Anne‐Marie Baird, Marvin Lim, Ray McDermott, Steven G. Gray, Lauren Brady, Ashvina Segaran, Simon Lord, Kent W. Hunter and Richard H. Simon and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Scientific Reports.

In The Last Decade

John Greene

29 papers receiving 991 citations

Hit Papers

Circular RNAs: Biogenesis, Function and Role in Human Dis... 2017 2026 2020 2023 2017 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Greene Ireland 11 754 588 160 102 58 38 1.0k
Annika Fendler Germany 18 797 1.1× 662 1.1× 166 1.0× 211 2.1× 58 1.0× 29 1.1k
Matthieu Schoenhals Madagascar 12 737 1.0× 458 0.8× 422 2.6× 58 0.6× 80 1.4× 28 1.1k
Marco Mazzotta Italy 14 365 0.5× 292 0.5× 317 2.0× 175 1.7× 77 1.3× 40 846
Patrick T. Hennessey United States 13 474 0.6× 227 0.4× 118 0.7× 92 0.9× 96 1.7× 15 775
Ludi Yang China 14 339 0.4× 232 0.4× 243 1.5× 63 0.6× 80 1.4× 40 636
Hongxia Li China 14 337 0.4× 247 0.4× 126 0.8× 64 0.6× 62 1.1× 39 575
M. Amneus United States 10 354 0.5× 245 0.4× 139 0.9× 67 0.7× 78 1.3× 18 854
Xiuqing Dong China 16 379 0.5× 312 0.5× 221 1.4× 143 1.4× 176 3.0× 36 779
Wenjun Liang China 11 396 0.5× 206 0.4× 133 0.8× 139 1.4× 105 1.8× 23 658

Countries citing papers authored by John Greene

Since Specialization
Citations

This map shows the geographic impact of John Greene's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Greene with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Greene more than expected).

Fields of papers citing papers by John Greene

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Greene. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Greene. The network helps show where John Greene may publish in the future.

Co-authorship network of co-authors of John Greene

This figure shows the co-authorship network connecting the top 25 collaborators of John Greene. A scholar is included among the top collaborators of John Greene based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Greene. John Greene is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lam, Holly Ching Yu, et al.. (2025). Malignant Fungating Wounds in Locally Aggressive Cutaneous Squamous Cell Carcinoma: A Case Series. Cureus. 17(3). e81114–e81114.
2.
Bates, Mark, Laura Byrne, John Greene, et al.. (2025). FOXP3 is a favourable prognostic indicator in oesophageal adenocarcinoma. Pathology - Research and Practice. 275. 156216–156216.
3.
4.
Singh, Karandeep & John Greene. (2024). Emphysematous Pyelonephritis in Cancer Patients: A Case Report With a Literature Review. Cureus. 16(7). e65000–e65000.
5.
Greene, John, Ashvina Segaran, & Simon Lord. (2022). Targeting OXPHOS and the electron transport chain in cancer; Molecular and therapeutic implications. Seminars in Cancer Biology. 86(Pt 2). 851–859. 133 indexed citations
6.
Greene, John, et al.. (2022). Nocardia niwae Disseminated Nocardiosis: A Novel Species Presenting Concurrently With Lung Adenocarcinoma. Cureus. 14(11). e31246–e31246. 2 indexed citations
7.
Mullally, William, John Greene, Emmet Jordan, et al.. (2022). The prognostic value of the derived neutrophil-to-lymphocyte ratio (dNLR) in patients treated with immune checkpoint inhibitors. Irish Journal of Medical Science (1971 -). 192(1). 83–87. 4 indexed citations
8.
Greene, John, Anne‐Marie Baird, Marvin Lim, et al.. (2021). Differential CircRNA Expression Signatures May Serve as Potential Novel Biomarkers in Prostate Cancer. Frontiers in Cell and Developmental Biology. 9. 605686–605686. 15 indexed citations
9.
Lim, Marvin, Anne‐Marie Baird, John Greene, et al.. (2021). hsa_circ_0001275 Is One of a Number of circRNAs Dysregulated in Enzalutamide Resistant Prostate Cancer and Confers Enzalutamide Resistance In Vitro. Cancers. 13(24). 6383–6383. 8 indexed citations
10.
Donlon, Noel E., Maria Davern, Fiona O’Connell, et al.. (2020). Linking Circulating Serum Proteins with Clinical Outcomes in Esophageal Adenocarcinoma—An Emerging Role for Chemokines. Cancers. 12(11). 3356–3356. 15 indexed citations
11.
Flynn, Louise, Martin P. Barr, Anne‐Marie Baird, et al.. (2020). Prostate cancer-derived holoclones: a novel and effective model for evaluating cancer stemness. Scientific Reports. 10(1). 11329–11329. 10 indexed citations
12.
Greene, John, William Mullally, Yasar Ahmed, et al.. (2020). Maintaining a Medical Oncology Service during the Covid-19 Pandemic.. PubMed. 113(5). 77–77. 1 indexed citations
13.
Mullally, William, et al.. (2018). Safety and tolerability of adjuvant FOLFOX vs. CAPOX in colon cancer: A real-world experience.. Journal of Clinical Oncology. 36(15_suppl). e15689–e15689. 1 indexed citations
14.
Taylor, Andrew, John Greene, Dennis Eshima, & Dirck L. Dillehay. (2015). Preliminary Results Comparing the Extraction Efficiencies of 131I-OIH and 99mTc-MAG3 in Rat Models of Ischemia, Renal Artery Stenosis, and Ciclosporin Toxicity1. Contributions to nephrology. 79. 21–23.
15.
Greene, John & Bryan T. Hennessy. (2014). The role of anthracyclines in the treatment of early breast cancer. Journal of Oncology Pharmacy Practice. 21(3). 201–212. 24 indexed citations
16.
Korpanty, Grzegorz, et al.. (2012). Bronchoesophageal Fistula in a Patient With Stage IIIB Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology. 7(10). 1622–1622. 3 indexed citations
17.
Greene, John. (2009). Promoting Programs through Performance: A Practical Guide. ˜The œFrench review. 82(6). 303–10. 1 indexed citations
18.
Jayaram, Hiremagalur N., Joel A. Yalowitz, Francisco Arguello, & John Greene. (2002). Toxicity and Efficacy of Benzamide Riboside in Cancer Chemotherapy Models. Current Medicinal Chemistry. 9(7). 787–792. 12 indexed citations
19.
Maxwell, Susan, et al.. (2001). Effectiveness of Reminder Systems on Appointment Adherence Rates. Journal of Health Care for the Poor and Underserved. 12(4). 504–514. 26 indexed citations
20.
Greene, John. (1973). The Provincial Archives of Newfoundland. Acadiensis. 3(1). 72–72.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026